KLISYRI ong 2.5 mg/250mg sach 5 pce

7680683220013 CH-68322 D06BX03 07.16.4.

Reimbursement limitations:

KLISYRI

KLISYRI est remboursé pour le traitement topique de champ des kératoses actiniques non hyperkératosiques et …

KLISYRI ong 2.5 mg/250mg sach 5 pce
KLISYRI ong 2.5 mg/250mg sach 5 pce
KLISYRI ong 2.5 mg/250mg sach 5 pce
1 / 3
google

Details

Product number
6832201
CPT
-
Packaging group
5
Unit
Beutel
Composition
tirbanibulinum 10 mg, glyceroli monostearas 40-55, propylenglycolum 890 mg, ad unguentum pro 1 g.

Articles (1)

Klisyri, Salbe
Salbe
5
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
07/02/2024
Professional SmPC
Français
07/02/2024
Professional SmPC
Italien
07/02/2024
Patient information leaflet
Allemand
31/03/2022
Patient information leaflet
Français
31/03/2022
Patient information leaflet
Italien
31/03/2022

Detailed composition

Substance Quantity Type Category
(N/A)
10.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
890.0 MG Substance HBESI

Reimbursement information

Public price
CHF 67.05
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/06/2022

Authorization holder

Almirall AG

8304 Wallisellen

Authorization information

Swissmedic authorization number
68322
Drug name
Klisyri, Salbe
Galenic form
SALB
ATC Code
D06BX03
Authorization status
Z
Dispensation category
A
First authorization
03/02/2022
Authorization expiration date
02/02/2027
IT number
07.16.4.
Domain
Human medicine
Field of application
Aktinische Keratose

Packaging details

Description (FR)
KLISYRI ong 2.5 mg/250mg sach 5 pce
Description (DE)
KLISYRI Salbe 2.5 mg/250mg Btl 5 Stk
Market launch
03/02/2022
Narcotic (BTM)
No